Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Veronese

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Cancer|March 12, 1998
Bax immunohistochemical expression in breast carcinoma: a study with long term follow-upS Veronese, F A Mauri, O Caffo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-upO Caffo, C Doglioni, S Veronese, et al.
Leukemia|October 31, 2003
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1HM Montillo, A Tedeschi, V Rossi, et al.
International Journal of Cancer|June 22, 2000
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-upM Barbareschi, H van Tinteren, F A Mauri, et al.
Human Pathology|November 1, 1996
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-upM Barbareschi, O Caffo, S Veronese, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 30, 2016
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventoriesA M Giovannetti, E Pietrolongo, A Giordano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2015
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trialE Rulli, M Marabese, V Torri, et al.
Trials|February 18, 2016
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'A Solari, A Giordano, M G Grasso, et al.
European Journal of Neurology|May 30, 2020
EAN guideline on palliative care of people with severe, progressive multiple sclerosisA Solari, A Giordano, J Sastre-Garriga, et al.
European Journal of Neurology|July 24, 2018
Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosisS Köpke, A Giordano, S Veronese, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Cancer|March 12, 1998
Bax immunohistochemical expression in breast carcinoma: a study with long term follow-upS Veronese, F A Mauri, O Caffo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1996
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-upO Caffo, C Doglioni, S Veronese, et al.
Leukemia|October 31, 2003
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1HM Montillo, A Tedeschi, V Rossi, et al.
International Journal of Cancer|June 22, 2000
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-upM Barbareschi, H van Tinteren, F A Mauri, et al.
Human Pathology|November 1, 1996
Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-upM Barbareschi, O Caffo, S Veronese, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 30, 2016
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventoriesA M Giovannetti, E Pietrolongo, A Giordano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2015
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trialE Rulli, M Marabese, V Torri, et al.
Trials|February 18, 2016
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'A Solari, A Giordano, M G Grasso, et al.
European Journal of Neurology|May 30, 2020
EAN guideline on palliative care of people with severe, progressive multiple sclerosisA Solari, A Giordano, J Sastre-Garriga, et al.
European Journal of Neurology|July 24, 2018
Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosisS Köpke, A Giordano, S Veronese, et al.
Pageof 4